PK/PD Modeling and Simulation Software

Understand the Safety and Efficacy Profile of Drugs in Development

Phoenix® is the industry’s premier software platform for managing, analyzing and reporting pharmacokinetic (PK), pharmacodynamic (PD) and toxicokinetic (TK) data. It is used by pharmaceutical, veterinary and academic researchers, along with the FDA and other global regulatory agencies, to understand the safety and efficacy profile of drugs in development.

Leverage All the Tools You Need From a Single Platform

Using one set of tools, the Phoenix platform becomes a valuable long term asset, rather than an ongoing expense of adding additional point products. It enhances the ability to share preclinical and clinical knowledge throughout the organization and track a drug through the development lifecycle. 

One Platform. Multiple Solutions.

  • Phoenix WinNonlin® is the industry-standard for Non-Compartmental Analysis (NCA) and PK/PD modeling and simulation.
  • Phoenix NLME™ is a powerful data processing and modeling tool for population PK/PD analysis.
  • Phoenix Connect™ streamlines report generation and provides connections between the Phoenix platform and the clinical data repository, PKS and 3rd party pharmacometrics tools.
  • IVIVC Toolkit for Phoenix WinNonlin brings enhanced deconvolution methods, numerical convolution, new plotting capabilities, and the “IVIVC Wizard” to pharmacokineticists and formulators.
  • AutoPilot Toolkit for Phoenix, integrated with WinNonlin and PKS Workflows, generates report-ready tables, figures and listings for regulatory submissions, interim reports and presentations.
  • Phoenix Knowledgebase Server is a secure Oracle®-based data repository that supports 21 CFR Part 11 compliance requirements by providing full audit trail and version control analyses performed within any Phoenix application.

Phoenix supports the concepts set forth in the Critical Path, an FDA program focused on the development of new tools to streamline drug development.